GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Citius Oncology CTOR · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.55

+7.85%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Citius Oncology

Our reporting

We have not reported on Citius Oncology yet.

Next results

17 Dec 2026

Due on 17 Dec 2026. Analysts expect earnings of -0.07 a share on revenue of $3.3m.

Past results

Reported against what analysts expected

14 Aug 202615 May 202613 Feb 202623 Dec 202512 Aug 202514 Feb 2025
Earnings per share-0.08-0.27-0.06-0.06-0.08-0.09
Forecast-0.07-0.01-0.04-0.06-0.15-0.06
Revenue$1.5m$1.7m$3.9m———
Forecast$2.5m$7.0m$4.4m———

Key events

  1. 13 Aug 20241-to-1 reverse split
  2. 14 Oct 2022Listed

Citius Oncology in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.